Cargando…
Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells
BACKGROUND: Hepatocellular carcinoma (HCC) is a lethal malignancy with high rate of metastasis and poor prognosis. There are no effective managements to block metastasis of HCC. Programmed cell death 4 (PDCD4) is found to be a tumor transformation suppressor. Among investigations on effects of PDCD4...
Autores principales: | Zhang, Shuhong, Li, Jianfeng, Jiang, Ying, Xu, Yijun, Qin, Chengyong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705348/ https://www.ncbi.nlm.nih.gov/pubmed/19480673 http://dx.doi.org/10.1186/1756-9966-28-71 |
Ejemplares similares
-
The possible role of Cytochrome c and programmed cell death protein 4 (PDCD4) on pathogenesis of hepatocellular carcinoma
por: Afify, Mei, et al.
Publicado: (2015) -
Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer
por: Wei, Na, et al.
Publicado: (2012) -
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma
por: Galuppini, Francesca, et al.
Publicado: (2019) -
Metastastic vulvar squamous cell carcinoma mimicking genital herpes
por: Bahner, Jennifer D., et al.
Publicado: (2016) -
Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
por: Wei, Na, et al.
Publicado: (2009)